Showing results (301-310 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.The Lancet. Diabetes & Endocrinology|November 4, 2018
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UKKrishnan Bhaskaran, Isabel Dos-Santos-Silva, David A Leon, et al.The Lancet. Diabetes & Endocrinology|March 28, 2017
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trialVanita R Aroda, Stephen C Bain, Bertrand Cariou, et al.The Lancet. Diabetes & Endocrinology|November 7, 2018
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trialMarc P Bonaca, J Antonio Gutierrez, Christopher Cannon, et al.The Lancet. Diabetes & Endocrinology|December 5, 2016
Hyperinsulinaemic hypoglycaemia in children and adultsPratik Shah, Sofia A Rahman, Huseyin Demirbilek, et al.The Lancet. Diabetes & Endocrinology|December 6, 2016
Oestrogen and anti-androgen therapy for transgender womenVin Tangpricha, Martin den HeijerThe Lancet. Diabetes & Endocrinology|March 1, 2014
Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort studyChristopher D Still, G Craig Wood, Peter Benotti, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysisCaroline Kaercher Kramer, Bernard Zinman, Ravi RetnakaranThe Lancet. Diabetes & Endocrinology|March 14, 2014
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort studyKristine Færch, Daniel R Witte, Adam G Tabák, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectivesMarkus J Seibel, Mark S Cooper, Hong ZhouPageof 93